Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by JULIE BOOM and LEILA SAHNI.
JULIE BOOM
Connection Strength
9.853
LEILA SAHNI
  1. Factors Associated With COVID-19 Non-vaccination in Adolescents Hospitalized Without COVID-19. J Pediatric Infect Dis Soc. 2023 Feb 09; 12(1):29-35.
    View in: PubMed
    Score: 0.777
  2. Sustained Within-season Vaccine Effectiveness Against Influenza-associated Hospitalization in Children: Evidence From the New Vaccine Surveillance Network, 2015-2016 Through 2019-2020. Clin Infect Dis. 2023 02 08; 76(3):e1031-e1039.
    View in: PubMed
    Score: 0.777
  3. Comparison of Mid-Turbinate and Nasopharyngeal Specimens for Molecular Detection of SARS-CoV-2 Among Symptomatic Outpatients at a Pediatric Drive-Through Testing Site. J Pediatric Infect Dis Soc. 2021 Sep 23; 10(8):872-879.
    View in: PubMed
    Score: 0.706
  4. Arboviral Surveillance among Pediatric Patients with Acute Febrile Illness in Houston, Texas. Am J Trop Med Hyg. 2018 08; 99(2):413-416.
    View in: PubMed
    Score: 0.561
  5. Understanding the Financial Implications of Immunization Reminder/Recall in a Multipractice Pediatric Group. Acad Pediatr. 2017 04; 17(3):323-329.
    View in: PubMed
    Score: 0.481
  6. Variation in rotavirus vaccine coverage by provider location and subsequent disease burden. Pediatrics. 2015 Feb; 135(2):e432-9.
    View in: PubMed
    Score: 0.444
  7. Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: a case series. J Infect Dis. 2012 Oct; 206(8):1275-9.
    View in: PubMed
    Score: 0.375
  8. Respiratory Viral Detection and Invasive Bacterial Infections in Infants =90 Days. Pediatr Infect Dis J. 2026 Aug 10.
    View in: PubMed
    Score: 0.248
  9. Adherence to hepatitis B birth dose vaccine recommendations in two hospital systems in Houston. Vaccine. 2026 Apr 30; 80:128564.
    View in: PubMed
    Score: 0.242
  10. Embracing Professionalism to Cultivate Vaccine Positivity and Reduce Vaccine Hesitancy. Pediatr Ann. 2024 Dec; 53(12):e465-e472.
    View in: PubMed
    Score: 0.220
  11. Maternal Vaccine Effectiveness Against Influenza-Associated Hospitalizations and Emergency Department Visits in Infants. JAMA Pediatr. 2024 02 01; 178(2):176-184.
    View in: PubMed
    Score: 0.208
  12. Beliefs about causes of autism and vaccine hesitancy among parents of children with autism spectrum disorder. Vaccine. 2020 09 11; 38(40):6327-6333.
    View in: PubMed
    Score: 0.163
  13. Vaccine Hesitancy and Illness Perceptions: Comparing Parents of Children with Autism Spectrum Disorder to other Parent Groups. Child Health Care. 2020; 49(4):385-402.
    View in: PubMed
    Score: 0.159
  14. Parental report of vaccine receipt in children with autism spectrum disorder: Do rates differ by pattern of ASD onset? Vaccine. 2016 Mar 08; 34(11):1335-42.
    View in: PubMed
    Score: 0.120
  15. The Texas Children's Hospital immunization forecaster: conceptualization to implementation. Am J Public Health. 2014 Dec; 104(12):e65-71.
    View in: PubMed
    Score: 0.109
  16. Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital. Pediatr Infect Dis J. 2010 Dec; 29(12):1133-5.
    View in: PubMed
    Score: 0.083
  17. Immunization information system opt-in consent: at what cost? J Public Health Manag Pract. 2010 Sep-Oct; 16(5):E18-25.
    View in: PubMed
    Score: 0.082
  18. Use of an immunization information system to assess the effectiveness of pentavalent rotavirus vaccine in US children. Vaccine. 2010 Aug 31; 28(38):6314-7.
    View in: PubMed
    Score: 0.081
  19. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics. 2010 Feb; 125(2):e199-207.
    View in: PubMed
    Score: 0.079
  20. Sociodemographic and Clinical Factors Associated With Nirsevimab Receipt Among Children Aged Younger Than 20 Months in the New Vaccine Surveillance Network in 2023 to 2025. Hosp Pediatr. 2026 Aug 27.
    View in: PubMed
    Score: 0.062
  21. The Humoral Immune Profiles of Infants Before and After Severe Primary RSV/A and RSV/B Infection. J Infect Dis. 2026 Aug 12.
    View in: PubMed
    Score: 0.062
  22. The New Vaccine Surveillance Network: 25 years of active, population-based surveillance for pediatric infectious diseases in the United States. Clin Infect Dis. 2026 Jul 13.
    View in: PubMed
    Score: 0.062
  23. Rotavirus Vaccine Coverage and Potential Barriers Among US Children Born From 2007 to 2024. Pediatrics. 2026 Jul 01; 158(1).
    View in: PubMed
    Score: 0.061
  24. Evolutionary dynamics of Respiratory Syncytial Virus in pre-pandemic, pandemic, and post-pandemic periods in Houston, Texas, USA. bioRxiv. 2026 Jun 17.
    View in: PubMed
    Score: 0.061
  25. Pediatric Vaccine Effectiveness Against Influenza Hospitalization and Outpatient Visits: 2021-2024. Pediatrics. 2026 May 01; 157(5).
    View in: PubMed
    Score: 0.061
  26. Effectiveness and Impact of Maternal RSV Immunization and Nirsevimab on Medically Attended RSV in US Children. JAMA Pediatr. 2026 Mar 01; 180(3):314-324.
    View in: PubMed
    Score: 0.060
  27. Hospitalization Outcomes of Full-Term and Premature Children Aged Less Than 2?Years Hospitalized With RSV. Pediatrics. 2026 Feb 01; 157(2).
    View in: PubMed
    Score: 0.060
  28. Influenza Vaccine Effectiveness Among Children With and Without Underlying Conditions. Pediatrics. 2026 Feb 01; 157(2).
    View in: PubMed
    Score: 0.060
  29. Influenza Antiviral Use in Hospitalized Children Before and During the COVID-19 Pandemic. Pediatrics. 2026 Feb 01; 157(2).
    View in: PubMed
    Score: 0.060
  30. Adenovirus Types in US Children Hospitalized or Seen in the Emergency Department With Acute Respiratory Illness, 2016-2019. Open Forum Infect Dis. 2025 Dec; 12(12):ofaf692.
    View in: PubMed
    Score: 0.059
  31. Viral Detection in Children <5?Years with Bronchiolitis, Pneumonia, and Croup, New Vaccine Surveillance Network, 2017-2023. J Pediatric Infect Dis Soc. 2025 Nov 01; 14(11).
    View in: PubMed
    Score: 0.059
  32. Antiviral Use Among Children Hospitalized With Laboratory-Confirmed Influenza Illness: A Prospective, Multicenter Surveillance Study. Clin Infect Dis. 2025 10 06; 81(3):623-633.
    View in: PubMed
    Score: 0.058
  33. Changes in Antiviral Prescribing for Children With Influenza in US Emergency Departments. JAMA Netw Open. 2025 10 01; 8(10):e2538729.
    View in: PubMed
    Score: 0.058
  34. Clinical Testing for COVID-19, Influenza, and RSV in Hospitalized Youths, 2016-2024. JAMA Netw Open. 2025 Sep 02; 8(9):e2531499.
    View in: PubMed
    Score: 0.058
  35. Human Metapneumovirus and Respiratory Syncytial Virus in Children: A Comparative Analysis. Pediatrics. 2025 Sep 01; 156(3).
    View in: PubMed
    Score: 0.058
  36. Acute Gastroenteritis Among Household Contacts of Children with Severe Norovirus Gastroenteritis, United States, 2011-2016. J Pediatric Infect Dis Soc. 2025 Jun 16; 14(6).
    View in: PubMed
    Score: 0.057
  37. Adenovirus Species in U.S. Children With Acute Respiratory Illness, 2016-2019. J Pediatric Infect Dis Soc. 2025 Jun 16; 14(6).
    View in: PubMed
    Score: 0.057
  38. Prevalence of human adenovirus in children with acute gastroenteritis in the New Vaccine Surveillance Network (NVSN) from 2016 to 2019. J Clin Virol. 2025 Aug; 179:105822.
    View in: PubMed
    Score: 0.057
  39. Antiviral Prescription in Children With Influenza in US Emergency Departments: New Vaccine Surveillance Network (NVSN), 2016-2020. Influenza Other Respir Viruses. 2025 06; 19(6):e70124.
    View in: PubMed
    Score: 0.057
  40. Epidemiology and genotypic diversity of rhinovirus in school-age children with acute respiratory illnesses seeking medical care. J Clin Virol. 2025 Aug; 179:105806.
    View in: PubMed
    Score: 0.057
  41. Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products - United States, October 2024-February 2025. MMWR Morb Mortal Wkly Rep. 2025 May 08; 74(16):273-281.
    View in: PubMed
    Score: 0.057
  42. Enterovirus D68-Associated Respiratory Illness in Children. JAMA Netw Open. 2025 05 01; 8(5):e259131.
    View in: PubMed
    Score: 0.057
  43. The Epidemiology and Burden of Human Parainfluenza Virus Hospitalizations in US Children. J Pediatric Infect Dis Soc. 2025 Apr 08; 14(4).
    View in: PubMed
    Score: 0.056
  44. Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024. JAMA Pediatr. 2025 02 01; 179(2):179-187.
    View in: PubMed
    Score: 0.056
  45. Pediatric Clinical Influenza Disease by Type and Subtype 2015-2020: A Multicenter, Prospective Study. J Pediatric Infect Dis Soc. 2025 Jan 20; 14(1).
    View in: PubMed
    Score: 0.056
  46. Estimated Vaccine Effectiveness for Pediatric Patients With Severe Influenza, 2015-2020. JAMA Netw Open. 2024 12 02; 7(12):e2452512.
    View in: PubMed
    Score: 0.055
  47. Underutilization of Influenza Antiviral Treatment Among Children and Adolescents at Higher Risk for Influenza-Associated Complications - United States, 2023-2024. MMWR Morb Mortal Wkly Rep. 2024 Nov 14; 73(45):1022-1029.
    View in: PubMed
    Score: 0.055
  48. Evaluation of a Modified Vesikari Severity Score as a Research Tool for Assessing Pediatric Acute Gastroenteritis. J Pediatric Infect Dis Soc. 2024 Nov 04; 13(10):547-550.
    View in: PubMed
    Score: 0.055
  49. On-time childhood vaccination before and during the COVID-19 pandemic in seven communities: Findings from the New Vaccine Surveillance Network. Vaccine. 2024 12 02; 42(26):126455.
    View in: PubMed
    Score: 0.055
  50. Rotavirus Vaccine Effectiveness Against Severe Acute Gastroenteritis: 2009-2022. Pediatrics. 2024 Oct 01; 154(4).
    View in: PubMed
    Score: 0.054
  51. Prevalence of SARS-CoV-2 in Children Identified by Preprocedural Testing at 5 US Children's Hospital Systems. Pediatr Infect Dis J. 2025 Jan 01; 44(1):47-53.
    View in: PubMed
    Score: 0.054
  52. Timing of influenza vaccination during pregnancy. Am J Obstet Gynecol MFM. 2024 08; 6(8):101427.
    View in: PubMed
    Score: 0.054
  53. Respiratory Syncytial Virus-Associated Hospitalizations in Children <5 Years: 2016-2022. Pediatrics. 2024 Jul 01; 154(1).
    View in: PubMed
    Score: 0.053
  54. Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron-Associated Hospitalization in Children and Adolescents - United States, 2021-2023. MMWR Morb Mortal Wkly Rep. 2024 Apr 18; 73(15):330-338.
    View in: PubMed
    Score: 0.053
  55. Accuracy of Influenza ICD-10 Diagnosis Codes in Identifying Influenza Illness in Children. JAMA Netw Open. 2024 04 01; 7(4):e248255.
    View in: PubMed
    Score: 0.053
  56. Medical Costs of Respiratory Syncytial Virus-Associated Hospitalizations and Emergency Department Visits in Children Aged Younger Than 5?Years: Observational Findings from the New Vaccine Surveillance Network, 2016-2019. J Pediatr. 2024 08; 271:114045.
    View in: PubMed
    Score: 0.053
  57. Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024. MMWR Morb Mortal Wkly Rep. 2024 Mar 07; 73(9):209-214.
    View in: PubMed
    Score: 0.052
  58. Respiratory Syncytial Virus-Associated Hospitalizations Among Children <5 Years Old: 2016 to 2020. Pediatrics. 2024 Mar 01; 153(3).
    View in: PubMed
    Score: 0.052
  59. Respiratory viral detection in the plasma and cerebrospinal fluid (CSF) of young febrile infants. Influenza Other Respir Viruses. 2024 02; 18(2):e13250.
    View in: PubMed
    Score: 0.052
  60. Characteristics and Clinical Outcomes of Vaccine-Eligible US Children Under-5 Years Hospitalized for Acute COVID-19 in a National Network. Pediatr Infect Dis J. 2024 Mar 01; 43(3):242-249.
    View in: PubMed
    Score: 0.052
  61. SARS-CoV-2 Epidemiology and COVID-19 mRNA Vaccine Effectiveness Among Infants and Children Aged 6 Months-4 Years - New Vaccine Surveillance Network, United States, July 2022-September 2023. MMWR Morb Mortal Wkly Rep. 2023 Dec 01; 72(48):1300-1306.
    View in: PubMed
    Score: 0.051
  62. Effectiveness of Maternal mRNA COVID-19 Vaccination During Pregnancy Against COVID-19-Associated Hospitalizations in Infants Aged <6 Months During SARS-CoV-2 Omicron Predominance - 20 States, March 9, 2022-May 31, 2023. MMWR Morb Mortal Wkly Rep. 2023 Sep 29; 72(39):1057-1064.
    View in: PubMed
    Score: 0.051
  63. BNT162b2 mRNA Vaccination Against Coronavirus Disease 2019 is Associated With a Decreased Likelihood of Multisystem Inflammatory Syndrome in Children Aged 5-18 Years-United States, July 2021 - April 2022. Clin Infect Dis. 2023 02 08; 76(3):e90-e100.
    View in: PubMed
    Score: 0.049
  64. Circulation of Rhinoviruses and/or Enteroviruses in Pediatric Patients With Acute Respiratory Illness Before and During the COVID-19 Pandemic in the US. JAMA Netw Open. 2023 02 01; 6(2):e2254909.
    View in: PubMed
    Score: 0.049
  65. Clinical Presentation and Severity of Adenovirus Detection Alone vs Adenovirus Co-detection With Other Respiratory Viruses in US Children With Acute Respiratory Illness from 2016 to 2018. J Pediatric Infect Dis Soc. 2022 Oct 25; 11(10):430-439.
    View in: PubMed
    Score: 0.048
  66. Respiratory Virus Surveillance Among Children with Acute Respiratory Illnesses - New Vaccine Surveillance Network, United States, 2016-2021. MMWR Morb Mortal Wkly Rep. 2022 Oct 07; 71(40):1253-1259.
    View in: PubMed
    Score: 0.047
  67. Comparative analysis of three multiplex platforms for the detection of respiratory viral pathogens. J Clin Virol. 2022 11; 156:105274.
    View in: PubMed
    Score: 0.047
  68. Vaccine Effectiveness Against Influenza Hospitalization and Emergency Department Visits in 2 A(H3N2) Dominant Influenza Seasons Among Children <18 Years Old-New Vaccine Surveillance Network 2016-2017 and 2017-2018. J Infect Dis. 2022 08 12; 226(1):91-96.
    View in: PubMed
    Score: 0.047
  69. Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants. N Engl J Med. 2022 07 14; 387(2):109-119.
    View in: PubMed
    Score: 0.046
  70. Understanding Variation in Rotavirus Vaccine Effectiveness Estimates in the United States: The Role of Rotavirus Activity and Diagnostic Misclassification. Epidemiology. 2022 09 01; 33(5):660-668.
    View in: PubMed
    Score: 0.046
  71. BNT162b2 Protection against the Omicron Variant in Children and Adolescents. N Engl J Med. 2022 05 19; 386(20):1899-1909.
    View in: PubMed
    Score: 0.046
  72. Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19-Associated Hospitalization in Infants Aged <6 Months - 17 States, July 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022 Feb 18; 71(7):264-270.
    View in: PubMed
    Score: 0.045
  73. Clinical Influenza Testing Practices in Hospitalized Children at United States Medical Centers, 2015-2018. J Pediatric Infect Dis Soc. 2022 Jan 27; 11(1):5-8.
    View in: PubMed
    Score: 0.045
  74. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021. MMWR Morb Mortal Wkly Rep. 2022 Jan 14; 71(2):52-58.
    View in: PubMed
    Score: 0.045
  75. Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents. N Engl J Med. 2022 02 24; 386(8):713-723.
    View in: PubMed
    Score: 0.045
  76. Enterovirus D68-Associated Acute Respiratory Illness - New Vaccine Surveillance Network, United States, July-November 2018-2020. MMWR Morb Mortal Wkly Rep. 2021 Nov 26; 70(47):1623-1628.
    View in: PubMed
    Score: 0.045
  77. Multiplex PCR Pathogen Detection in Acute Gastroenteritis Among Hospitalized US Children Compared With Healthy Controls During 2011-2016 in the Post-Rotavirus Vaccine Era. Open Forum Infect Dis. 2021 Dec; 8(12):ofab592.
    View in: PubMed
    Score: 0.045
  78. Influenza clinical testing and oseltamivir treatment in hospitalized children with acute respiratory illness, 2015-2016. Influenza Other Respir Viruses. 2022 03; 16(2):289-297.
    View in: PubMed
    Score: 0.044
  79. Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years - United States, June-September 2021. MMWR Morb Mortal Wkly Rep. 2021 Oct 22; 70(42):1483-1488.
    View in: PubMed
    Score: 0.044
  80. Effect of Vaccination on Preventing Influenza-Associated Hospitalizations Among Children During a Severe Season Associated With B/Victoria Viruses, 2019-2020. Clin Infect Dis. 2021 08 16; 73(4):e947-e954.
    View in: PubMed
    Score: 0.044
  81. Understanding Vaccine Hesitancy Among Parents of Children With Autism Spectrum Disorder and Parents of Children With Non-Autism Developmental Delays. J Child Neurol. 2021 09; 36(10):911-918.
    View in: PubMed
    Score: 0.043
  82. Acute Respiratory Illnesses in Children in the SARS-CoV-2 Pandemic: Prospective Multicenter Study. Pediatrics. 2021 08; 148(2).
    View in: PubMed
    Score: 0.043
  83. Comparison of Parental Report of Influenza Vaccination to Documented Records in Children Hospitalized With Acute Respiratory Illness, 2015-2016. J Pediatric Infect Dis Soc. 2021 Apr 30; 10(4):389-397.
    View in: PubMed
    Score: 0.043
  84. Vaccine Effectiveness Against Influenza Hospitalization Among Children in the United States, 2015-2016. J Pediatric Infect Dis Soc. 2021 Mar 26; 10(2):75-82.
    View in: PubMed
    Score: 0.043
  85. Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children: Multicenter Surveillance, United States, January-March 2020. J Pediatric Infect Dis Soc. 2020 Nov 10; 9(5):609-612.
    View in: PubMed
    Score: 0.042
  86. Vaccine Effectiveness Against Pediatric Influenza Hospitalizations and Emergency Visits. Pediatrics. 2020 11; 146(5).
    View in: PubMed
    Score: 0.041
  87. Respiratory Syncytial Virus-Associated Hospitalizations Among Young Children: 2015-2016. Pediatrics. 2020 07; 146(1).
    View in: PubMed
    Score: 0.040
  88. Evidence for Household Transmission of Rotavirus in the United States, 2011-2016. J Pediatric Infect Dis Soc. 2020 Apr 30; 9(2):181-187.
    View in: PubMed
    Score: 0.040
  89. Evaluating Partial Series Childhood Vaccination Services in a Mobile Clinic Setting. Clin Pediatr (Phila). 2020 06; 59(7):706-715.
    View in: PubMed
    Score: 0.040
  90. Association of Rotavirus Vaccination With Inpatient and Emergency Department Visits Among Children Seeking Care for Acute Gastroenteritis, 2010-2016. JAMA Netw Open. 2019 09 04; 2(9):e1912242.
    View in: PubMed
    Score: 0.038
  91. Enterovirus D68-Associated Acute Respiratory Illness - New Vaccine Surveillance Network, United States, July-October, 2017 and 2018. MMWR Morb Mortal Wkly Rep. 2019 Mar 29; 68(12):277-280.
    View in: PubMed
    Score: 0.037
  92. Factors Associated With Rotavirus Vaccine Coverage. Pediatrics. 2019 02; 143(2).
    View in: PubMed
    Score: 0.037
  93. Rotavirus Strain Trends During the Postlicensure Vaccine Era: United States, 2008-2013. J Infect Dis. 2016 09 01; 214(5):732-8.
    View in: PubMed
    Score: 0.031
  94. Molecular characterization of the first G24P[14] rotavirus strain detected in humans. Infect Genet Evol. 2016 09; 43:338-42.
    View in: PubMed
    Score: 0.031
  95. G2P[4]-RotaTeq Reassortant Rotavirus in Vaccinated Child, United States. Emerg Infect Dis. 2015 Nov; 21(11):2103-4.
    View in: PubMed
    Score: 0.029
  96. Epidemiologic Association Between FUT2 Secretor Status and Severe Rotavirus Gastroenteritis in Children in the United States. JAMA Pediatr. 2015 Nov; 169(11):1040-5.
    View in: PubMed
    Score: 0.029
  97. Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013. Clin Infect Dis. 2015 Dec 15; 61(12):1792-9.
    View in: PubMed
    Score: 0.029
  98. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clin Infect Dis. 2013 Jul; 57(1):13-20.
    View in: PubMed
    Score: 0.024
  99. Detection of rotavirus antigenemia in routinely obtained serum specimens to augment surveillance and vaccine effectiveness evaluations. Pediatr Infect Dis J. 2010 Sep; 29(9):836-9.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.